Who we are

BioCurate is a bold, collaborative venture, dedicated to translating Australian medical research and delivering health and economic benefits to the world. Created jointly by two of Australia’s leading biomedical universities, the University of Melbourne and Monash University, we are operationally independent with an absolute commitment to rigorous science and partnering closely with researchers to help conquer the challenges which stand between great ideas and global impact. We can help you change the future.

We bridge the gap

Our collaborative team of global biomedical experts bridge the gap between:

Academia + Industry
Ideas + Impact
Discovery + Partnerships
Collaboration + Commercialisation
Research + Translation

What we are doing

Staff profiles

Our team

Has over 150 years of combined biotech/pharma industry experience

Has been directly involved in over 35 Investigational New Drug applications (INDs)

Are responsible for 70 therapeutics currently in the clinic

Were directly involved in 15 deals worth a cumulative total of over $2.1 billion

Twitter feed

BioCurate Director of Project Management Dr Cathy Drinkwater will be a judge at @MonashBDI's So You Think You Can Pitch? competition as part of their annual Industry Showcase. We look forward to hearing the pitches and their the potential to shape the nature of human disease.

Congratulations to Dr Tamsin Terry on her pitch ‘Octapeptin X – a novel antibiotic for Gram-negative bacterial infections’ which won the @BioCurate Best Translational Research award at the @AusBiotech Early Stage Investment Forum.

@UQ_News #research.


We are proud to be a sponsor of the #SOBR2020 symposium. We look forward to hearing the latest breakthroughs from our country's young and bright brain researchers.

Many commercially-available antibodies are substandard, misleading researchers with false positive results. There are a number of strategies to ensure scientific rigour when it comes to using research antibodies. Read more via https://nuvi.me/m6jxl2